Chao Ding1, Da-ming Jiang, Kai-yu Tao, Qun-jun Duan, Jie Li, Min-jian Kong, Zhong-hua Shen, Ai-qiang Dong. 1. Department of Gynaecology, Zhejiang Cancer Hospital, Hangzhou 310022, China; Department of Cardiovascular Surgery, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China; Guangdong Cardiovascular Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510030, China.
Abstract
OBJECTIVE: Mitral valve disease tends to be treated with anterolateral minithoracotomy (ALMT) rather than median sternotomy (MS), as ALMT uses progressively smaller incisions to promote better cosmetic outcomes. This meta-analysis quantifies the effects of ALMT on surgical parameters and post-operative outcomes compared with MS. METHODS: One randomized controlled study and four case-control studies, published in English from January 1996 to January 2013, were identified and evaluated. RESULTS: ALMT showed a significantly longer cardiopulmonary bypass time (P=0.001) and aortic cross-clamp time (P=0.05) compared with MS. However, the benefits of ALMT were evident as demonstrated by a shorter length of hospital stay (P<0.00001). According to operative complications, the onset of new arrhythmias following ALMT decreased significantly as compared with MS (P=0.05); however, the incidence of peri-operative mortality (P=0.62), re-operation for bleeding (P=0.37), neurologic events (P=0.77), myocardial infarction (P=0.84), gastrointestinal complications (P=0.89), and renal insufficiency (P=0.67) were similar to these of MS. Long-term follow-up data were also examined, and revealed equivalent survival and freedom from mitral valve events. CONCLUSIONS: Current clinical data suggest that ALMT is a safe and effective alternative to the conventional approach and is associated with better short-term outcomes and a trend towards longer survival.
OBJECTIVE:Mitral valve disease tends to be treated with anterolateral minithoracotomy (ALMT) rather than median sternotomy (MS), as ALMT uses progressively smaller incisions to promote better cosmetic outcomes. This meta-analysis quantifies the effects of ALMT on surgical parameters and post-operative outcomes compared with MS. METHODS: One randomized controlled study and four case-control studies, published in English from January 1996 to January 2013, were identified and evaluated. RESULTS: ALMT showed a significantly longer cardiopulmonary bypass time (P=0.001) and aortic cross-clamp time (P=0.05) compared with MS. However, the benefits of ALMT were evident as demonstrated by a shorter length of hospital stay (P<0.00001). According to operative complications, the onset of new arrhythmias following ALMT decreased significantly as compared with MS (P=0.05); however, the incidence of peri-operative mortality (P=0.62), re-operation for bleeding (P=0.37), neurologic events (P=0.77), myocardial infarction (P=0.84), gastrointestinal complications (P=0.89), and renal insufficiency (P=0.67) were similar to these of MS. Long-term follow-up data were also examined, and revealed equivalent survival and freedom from mitral valve events. CONCLUSIONS: Current clinical data suggest that ALMT is a safe and effective alternative to the conventional approach and is associated with better short-term outcomes and a trend towards longer survival.
Authors: Eugene A Grossi; Aubrey C Galloway; Angelo LaPietra; Greg H Ribakove; Patricia Ursomanno; Julie Delianides; Alfred T Culliford; Costas Bizekis; Rick A Esposito; F Gregory Baumann; Marc S Kanchuger; Stephen B Colvin Journal: Ann Thorac Surg Date: 2002-09 Impact factor: 4.330
Authors: Joerg Seeburger; Michael Andrew Borger; Volkmar Falk; Thomas Kuntze; Markus Czesla; Thomas Walther; Nicolas Doll; Friedrich Wilhelm Mohr Journal: Eur J Cardiothorac Surg Date: 2008-06-30 Impact factor: 4.191
Authors: D F Loulmet; A Carpentier; P W Cho; A Berrebi; N d'Attellis; C B Austin; J P Couëtil; P Lajos Journal: J Thorac Cardiovasc Surg Date: 1998-04 Impact factor: 5.209
Authors: J G Byrne; M K Hsin; D H Adams; L Aklog; S F Aranki; G S Couper; R J Rizzo; L H Cohn Journal: J Card Surg Date: 2000 Jan-Feb Impact factor: 1.620
Authors: C R Asher; J M DiMengo; K L Arheart; M M Weber; R A Grimm; E H Blackstone; D M Cosgrove; M K Chung Journal: Am J Cardiol Date: 1999-09-15 Impact factor: 2.778
Authors: David M Holzhey; William Shi; Michael A Borger; Joerg Seeburger; Jens Garbade; Bettina Pfannmüller; Friedrich W Mohr Journal: Ann Thorac Surg Date: 2011-02 Impact factor: 4.330
Authors: Joerg Seeburger; Michael A Borger; Volkmar Falk; Jurgen Passage; Thomas Walther; Nicolas Doll; Friedrich W Mohr Journal: Ann Thorac Surg Date: 2009-03 Impact factor: 4.330
Authors: Maria Maimari; Nikolaos G Baikoussis; Stelios Gaitanakis; Anna Dalipi-Triantafillou; Andreas Katsaros; Charilaos Kantsos; Vasileios Lozos; Konstantinos Triantafillou Journal: Ann Card Anaesth Date: 2020 Jan-Mar
Authors: Rebecca H Maier; Adetayo S Kasim; Joseph Zacharias; Luke Vale; Richard Graham; Antony Walker; Grzegorz Laskawski; Ranjit Deshpande; Andrew Goodwin; Simon Kendall; Gavin J Murphy; Vipin Zamvar; Renzo Pessotto; Clinton Lloyd; Malcolm Dalrymple-Hay; Roberto Casula; Hunaid A Vohra; Franco Ciulli; Massimo Caputo; Serban Stoica; Max Baghai; Gunaratnam Niranjan; Prakash P Punjabi; Olaf Wendler; Leanne Marsay; Cristina Fernandez-Garcia; Paul Modi; Bilal H Kirmani; Mark D Pullan; Andrew D Muir; Dimitrios Pousios; Helen C Hancock; Enoch Akowuah Journal: BMJ Open Date: 2021-04-14 Impact factor: 2.692